Levamisole therapy was tested for its effect on herpetic trigeminal ganglionic latency in mice. There was no significant difference between recovery rate from levamisole-treated mice and that from non-treated mice during 12 weeks treatment. These results show that levamisole does not suppress herpetic ganglionic latency.